COVID-19 pandemic response
We continue to follow Government and University of Cambridge guidelines for staying COVID-safe. Our buildings are open for lab-based research work.
The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded MRC Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
The IMS-MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Welcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the IMS-MRL.
In a recent study funded by the British Heart Foundation, Guillaume Bidault and members of the TVP group, working with colleagues from the MRC…
A multi-centre study, involving researchers including Dr Agatha van der Klaauw and Prof Sadaf Farooqi, with others from across the University and beyond, has…
Congratulations to Isadora Clivatti Furigo, until recently a post-doctoral researcher in the Ozanne Group, on winning the 2021 Michael Harbuz Award. The Award is…
Congratulations to Professors Stephen O’Rahilly and Sadaf Farooqi who are announced today as winners of the Royal Society’s prestigious Croonian Medal “for their…